Follow
Eva M Lonn
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2010 update: a report from the American Heart Association
Writing Group Members, D Lloyd-Jones, RJ Adams, TM Brown, ...
Circulation 121 (7), e46-e215, 2010
74822010
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography …
JH Stein, CE Korcarz, RT Hurst, E Lonn, CB Kendall, ER Mohler, ...
Journal of the American Society of echocardiography 21 (2), 93-111, 2008
28182008
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
23292017
Homocysteine lowering with folic acid and B vitamins in vascular disease
Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
New England Journal of Medicine 354 (15), 1567-1577, 2006
23072006
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22242006
Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review
M Gianni, F Dentali, AM Grandi, G Sumner, R Hiralal, E Lonn
European heart journal 27 (13), 1523-1529, 2006
19312006
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, JM Arnold, C Ross, ...
Jama 293 (11), 1338-1347, 2005
14522005
Homocyst (e) ine and cardiovascular disease: a critical review of the epidemiologic evidence
JW Eikelboom, E Lonn, J Genest Jr, G Hankey, S Yusuf
Annals of internal medicine 131 (5), 363-375, 1999
13651999
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
SS Anand, S Yusuf, V Vuksan, S Devanesen, KK Teo, PA Montague, ...
The lancet 356 (9226), 279-284, 2000
13432000
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13162018
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult
TJ Anderson, J Grégoire, RA Hegele, P Couture, GBJ Mancini, ...
Canadian Journal of Cardiology 29 (2), 151-167, 2013
10842013
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations
J Genest, R McPherson, J Frohlich, T Anderson, N Campbell, ...
Canadian Journal of Cardiology 25 (10), 567-579, 2009
10692009
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)
EM Lonn, S Yusuf, V Dzavik, CI Doris, Q Yi, S Smith, A Moore-Cox, ...
Circulation 103 (7), 919-925, 2001
10632001
2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult
TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ...
Canadian Journal of Cardiology 32 (11), 1263-1282, 2016
10312016
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ...
New England Journal of Medicine 374 (21), 2021-2031, 2016
9942016
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis
HM Den Ruijter, SAE Peters, TJ Anderson, AR Britton, JM Dekker, ...
Jama 308 (8), 796-803, 2012
9232012
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
9132018
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ...
New England Journal of Medicine 374 (21), 2009-2020, 2016
7812016
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
EM Lonn, S Yusuf, P Jha, TJ Montague, KK Teo, CR Benedict, B Pitt
Circulation 90 (4), 2056-2069, 1994
7591994
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
J Mathew, P Sleight, E Lonn, D Johnstone, J Pogue, Q Yi, J Bosch, ...
Circulation 104 (14), 1615-1621, 2001
7492001
The system can't perform the operation now. Try again later.
Articles 1–20